Clinic
Lehigh Valley Hospital Hazleton
Lehigh Valley Hospital Hazleton was paid $11.69M by Medicaid between Jan 2018 and Dec 2024, across 227 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoLEHIGH VALLEY HOSPITAL HAZLETON
HAZLETON, PA 18201
HAZLETON, PA 18201
33aNPI1548322720assigned 12/14/2006
33bProvider typeClinic/Center
28Total paid$11.69M
24GClaims281,987
24DCodes billed227
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#14 of 176
Median peer was paid$441K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMAS, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 108 | $6K | |
| 2019 | 1,214 | $42K | |
| 2020 | 25,498 | $931K | |
| 2021 | 107,949 | $4.03M | |
| 2022 | 48,012 | $2.40M | |
| 2023 | 53,209 | $2.38M | |
| 2024incomplete | 45,997 | $1.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 22,431 | 21,616 | $3.43M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 16,946 | 16,463 | $1.99M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 11% | 31,529 | 8,450 | $1.30M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 3,357 | 3,250 | $496K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.0% | 4,977 | 3,487 | $346K |
| G0378 | Hospital observation service, per hour | 3.0% | 433 | 336 | $345K |
| X0621 | 2.5% | 1,277 | 760 | $292K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.0% | 2,354 | 2,251 | $229K |
| 80053 | Comprehensive metabolic panel | 1.7% | 19,591 | 18,400 | $198K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.5% | 465 | 463 | $178K |
| T1001 | Nursing assessment / evaluation | 1.4% | 1,017 | 1,005 | $167K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 1,103 | 1,081 | $152K |
215 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 2,728 | $137K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 1.1% | 3,412 | $125K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,076 | $106K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,933 | $103K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 827 | $70K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,426 | $68K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,314 | $61K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 807 | $59K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,149 | $59K |
| 99429 | <1% | 252 | $57K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 969 | $51K |
| 80061 | Lipid panel | <1% | 3,611 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,087 | $50K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,215 | $50K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 626 | $50K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 796 | $48K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 942 | $47K |
| S9470 | Nutritional counseling, dietitian visit | <1% | 2,667 | $47K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,030 | $42K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,640 | $41K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 719 | $39K |
| 76830 | Ultrasound, transvaginal | <1% | 763 | $37K |
| 86780 | <1% | 2,364 | $37K | |
| 80050 | General health panel | <1% | 951 | $37K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,364 | $32K |
| 86803 | <1% | 1,555 | $32K | |
| 87653 | <1% | 693 | $31K | |
| 84703 | <1% | 3,263 | $30K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 450 | $30K |
| 93975 | <1% | 273 | $29K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,505 | $29K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 396 | $27K |
| 76801 | <1% | 590 | $25K | |
| 97162 | <1% | 426 | $25K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 820 | $24K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 143 | $24K |
| 87631 | <1% | 169 | $23K | |
| 97164 | <1% | 610 | $23K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 410 | $22K |
| 84484 | <1% | 2,336 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,705 | $20K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 238 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,632 | $19K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 813 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 941 | $18K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 564 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,219 | $16K |
| 90715 | <1% | 1,311 | $15K | |
| 86762 | <1% | 977 | $15K | |
| 84702 | <1% | 855 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,160 | $14K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 252 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 468 | $14K |
| 76536 | <1% | 262 | $13K | |
| 83021 | <1% | 812 | $12K | |
| 86787 | <1% | 873 | $12K | |
| 85027 | <1% | 1,499 | $12K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 327 | $11K |
| 87340 | <1% | 902 | $10K | |
| 81001 | <1% | 4,170 | $10K | |
| 76642 | <1% | 248 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,371 | $10K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 236 | $10K |
| 86850 | <1% | 1,475 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,415 | $10K |
| 81003 | <1% | 3,529 | $9K | |
| 59426 | <1% | 12 | $9K | |
| 84466 | <1% | 525 | $9K | |
| 82728 | <1% | 722 | $9K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 163 | $8K |
| 97168 | <1% | 225 | $8K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 217 | $8K |
| 83690 | <1% | 2,033 | $8K | |
| 93017 | <1% | 195 | $7K | |
| 72110 | <1% | 384 | $7K | |
| 73564 | <1% | 340 | $7K | |
| 97161 | <1% | 121 | $7K | |
| 82950 | <1% | 925 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 725 | $6K |
| 71250 | <1% | 135 | $6K | |
| 86706 | <1% | 505 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 116 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 245 | $6K |
| 83880 | <1% | 259 | $6K | |
| 82607 | <1% | 399 | $5K | |
| 84439 | <1% | 643 | $5K | |
| 83540 | <1% | 611 | $5K | |
| 86901 | <1% | 1,512 | $5K | |
| 86900 | <1% | 1,512 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 521 | $5K |
| 97165 | <1% | 78 | $4K | |
| 84153 | <1% | 183 | $4K | |
| 85379 | <1% | 474 | $4K | |
| 73030 | <1% | 277 | $4K | |
| 86696 | <1% | 200 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 385 | $4K |
| 83735 | <1% | 651 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,542 | $4K |
| 94729 | <1% | 131 | $4K | |
| 72141 | <1% | 14 | $3K | |
| 83605 | <1% | 529 | $3K | |
| 86038 | <1% | 211 | $3K | |
| 84146 | <1% | 124 | $3K | |
| 82043 | <1% | 416 | $3K | |
| 93970 | <1% | 42 | $3K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $3K |
| 82947 | <1% | 1,186 | $3K | |
| 82570 | <1% | 436 | $3K | |
| 73610 | <1% | 199 | $3K | |
| 86618 | <1% | 130 | $3K | |
| 73630 | <1% | 293 | $3K | |
| 76770 | <1% | 72 | $3K | |
| 93971 | <1% | 44 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 67 | $3K |
| 85610 | <1% | 844 | $3K | |
| 81025 | <1% | 636 | $3K | |
| 93976 | <1% | 28 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 53 | $2K |
| 84403 | <1% | 74 | $2K | |
| 73130 | <1% | 182 | $2K | |
| 74018 | <1% | 156 | $2K | |
| 87040 | <1% | 140 | $2K | |
| 87077 | <1% | 310 | $2K | |
| 83525 | <1% | 166 | $2K | |
| 87186 | <1% | 283 | $2K | |
| 94726 | <1% | 76 | $2K | |
| 93296 | <1% | 195 | $2K | |
| 83721 | <1% | 144 | $2K | |
| 86695 | <1% | 126 | $2K | |
| 83655 | <1% | 148 | $2K | |
| 83001 | <1% | 87 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,231 | $2K |
| 85652 | <1% | 476 | $1K | |
| 82805 | <1% | 71 | $1K | |
| 93226 | <1% | 36 | $1K | |
| 80074 | <1% | 25 | $1K | |
| 76870 | <1% | 28 | $1K | |
| 82784 | <1% | 61 | $1K | |
| 70486 | <1% | 16 | $1K | |
| 73110 | <1% | 93 | $935.20 | |
| 77065 | Tomosynthesis, mammo | <1% | 14 | $921.46 |
| 86431 | <1% | 112 | $909.06 | |
| 86140 | <1% | 300 | $890.75 | |
| 82248 | <1% | 110 | $838.61 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,740 | $835.94 |
| 94010 | <1% | 116 | $806.25 | |
| 83002 | <1% | 44 | $775.54 | |
| 82746 | <1% | 64 | $744.05 | |
| 82247 | <1% | 96 | $743.12 | |
| 72050 | <1% | 27 | $716.78 | |
| 85730 | <1% | 122 | $706.32 | |
| 82550 | <1% | 107 | $697.80 | |
| 80076 | <1% | 78 | $666.53 | |
| 93225 | <1% | 37 | $647.64 | |
| 84436 | <1% | 64 | $618.41 | |
| 82962 | <1% | 472 | $618.19 | |
| 73502 | <1% | 41 | $609.99 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,869 | $578.17 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $578.05 |
| 84480 | <1% | 72 | $573.25 | |
| 76775 | <1% | 12 | $513.95 | |
| G0008 | Administration of influenza virus vaccine | <1% | 43 | $466.48 |
| 86225 | <1% | 27 | $401.07 | |
| 85007 | <1% | 81 | $398.91 | |
| 74022 | <1% | 16 | $344.03 | |
| 82670 | <1% | 15 | $342.74 | |
| 82951 | <1% | 24 | $330.88 | |
| 86617 | <1% | 15 | $323.29 | |
| 84550 | <1% | 53 | $312.51 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,519 | $292.03 |
| 86235 | <1% | 15 | $290.08 | |
| 84481 | <1% | 14 | $243.81 | |
| 72170 | <1% | 29 | $228.90 | |
| 86704 | <1% | 13 | $227.70 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 28 | $219.13 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,827 | $211.48 |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 14 | $211.22 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,313 | $206.59 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,075 | $202.29 |
| 86039 | <1% | 12 | $194.94 | |
| 82150 | <1% | 40 | $181.29 | |
| 86769 | <1% | 12 | $179.88 | |
| 86708 | <1% | 12 | $171.69 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,191 | $166.92 |
| 84100 | <1% | 28 | $153.04 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 268 | $145.49 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 442 | $105.05 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 798 | $100.78 |
| 84425 | <1% | 13 | $90.43 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 179 | $87.06 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 985 | $86.30 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,617 | $84.19 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 222 | $76.27 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 905 | $70.42 |
| 85045 | <1% | 14 | $58.96 | |
| 88142 | <1% | 13 | $54.24 | |
| 94760 | <1% | 26 | $53.97 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 27 | $51.93 |
| A9270 | Non-covered item or service | <1% | 3,193 | $31.49 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 60 | $13.11 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 100 | $7.76 |
| J1750 | Injection, iron dextran, 50 mg | 0% | 238 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 169 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 160 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 16 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 237 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 84 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 45 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 178 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 79 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 212 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 192 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 85 | $0.00 |
| 90686 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMAS, ROBERT (CHIEF ACCOUNTING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Millennium Health, LLC | San Diego, CA | $579.29M |
| Lehigh Valley Hospital | Allentown, PA | $64.40M |
| Lehigh Valley Hospital Pocono | East Stroudsburg, PA | $11.90M |
| Lehigh Valley Hospital | Allentown, PA | $10.00M |
| Lehigh Valley Hospital - Schuylkill | Pottsville, PA | $6.83M |
| Lehigh Valley Hospital- Pocono | Dickson City, PA | $3.75M |
| Lehigh Valley Hospital | Allentown, PA | $2.90M |
| Lehigh Valley Hospital | Allentown, PA | $1.95M |
| Lehigh Valley Hospital, INC | Allentown, PA | $1.85M |
| Lehigh Valley Hospital | Allentown, PA | $1.40M |
| Lehigh Valley Hospital - Schuylkill | Saint Clair, PA | $744K |
| Maryland Wound & Amputation Prevention, LLC | Lutherville, MD | $399K |
| Robert L Thomas MD FCCP LLC | Walterboro, SC | $253K |
| A-One Home Health Services, LLC | Everett, WA | $236K |
| Avamere Home Health Care, LLC | Bellingham, WA | $234K |
| Lehigh Valley Hospital Schuylkill | Pottsville, PA | $218K |
| Lehigh Valley Hospital Hazleton | Hazleton, PA | $193K |
| Prime Home Health, LLC | Federal Way, WA | $115K |
| Lehigh Valley Hospital | Allentown, PA | $70K |
| Northwest Hospice LLC | Tigard, OR | $33K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.